Integrating [18F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors
Prendergast C, Lopci E, Seban R, De Jong D, Ammari S, Aneja S, Lévy A, Sajan A, Salvatore M, Cappacione K, Schwartz L, Deutsch E, Dercle L. Integrating [18F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors. Cancers 2023, 15: 5179. PMID: 37958353, PMCID: PMC10648321, DOI: 10.3390/cancers15215179.Peer-Reviewed Original ResearchPET/CTRadiation therapyPositron emission tomographySolid tumorsEmission tomographyPrecision therapyCombination of RTFDG positron emission tomographyFluorodeoxyglucose positron emission tomographyDistant tumor sitesQuality of careComputed tomography (CT) imagingAdverse eventsAbscopal effectJoint guidelinesTreatment responseComputed tomographyIO administrationTumor siteTherapyTomography imagingIncremental valueTomographyTumorsCT